A detailed history of Cwm, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 4,161 shares of ESPR stock, worth $9,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,161
Previous 850 389.53%
Holding current value
$9,320
Previous $2,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$1.61 - $2.73 $5,330 - $9,039
3,311 Added 389.53%
4,161 $7,000
Q1 2023

Apr 28, 2023

BUY
$1.46 - $7.3 $730 - $3,650
500 Added 142.86%
850 $1,000
Q1 2022

Apr 21, 2022

BUY
$3.34 - $5.56 $1,002 - $1,667
300 Added 600.0%
350 $2,000
Q4 2021

Jan 31, 2022

BUY
$4.81 - $11.92 $240 - $596
50 New
50 $0

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $149M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.